Comparison of impact of primary percutaneous transluminal coronary angioplasty and primary stenting on short-term mortality in patients with cardiogenic shock and evaluation of prognostic determinants

American Journal of Cardiology

Volumn 87, Issue 10, 2001, Pages 1184-1188

  Yip, Hon Kan ^a   Wu, Chiung Jen ^a   Chang, Hsueh Wen ^b   Chen, Mien Cheng ^a   Hang, Chi Ling ^a   Fang, Chi Yuang ^a   Hsieh, Yuan Kai ^a   Yang, Cheng Hsu ^a   Yeh, Kuo Ho ^a   Fu, Morgan ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGED; ARTERY DIAMETER; ARTICLE; CARDIOGENIC SHOCK; CLINICAL FEATURE; COMPARATIVE STUDY; CONSERVATIVE TREATMENT; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY STENT; FEMALE; HEART MUSCLE REPERFUSION; HEART REINFARCTION; HUMAN; ISCHEMIA; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; STENOSIS; SYSTOLIC BLOOD PRESSURE; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY CIRCULATION; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SHOCK, CARDIOGENIC; STENTS; SURVIVAL RATE;

EID: 0035873450     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(01)01491-6     Document Type: Article

References (19)

1. Killip T., Kimball J.T. Treatment of myocardial infarction in a coronary care unit a two year experience with 250 patients . Am J Cardiol. 20:1967;457-459.
2. Goldberg R.J., Gore J.M., Alpert J.S., Osganian V., De Groot J., Bade J., Chen Z., Frid D., Dalen J.E. Cardiogenic shock after acute myocardial infarction incidence and mortality from a community-wide perspective, 1875 to 1988 . N Engl J Med. 325:1991;1117-1122.
3. Berger P.B., Holmes D.R., Stebbins A.L., Bates E.R., Califf M.R., Topol E.J. Impact of an aggressive invasive cardiogenic shock in the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries (GUSTO-I) trial an observational study . Circulation. 96:1997;122-127.
4. Hochman J.S., Sleeper L.A., Webb F.G., Sanborn T.A., White H.D., Talley D., Buller C.E., Jacobs A.K., Slater J.N., Col J., McKinlay S.M., LeJemtel T.H. Early revascularization in acute myocardial infarction complicated by cardiogenic shock for the shock investigators . N Engl J Med. 341:1999;625-634.
5. Antoniucci D., Valenti R., Santoro G.M., Bolognese L., Trapani M., Moschi G., Fazzini P.F. Systemic direct angioplasty and stent-supported direct angioplasty therapy for cardiogenic shock complicating acute myocardial infarction in-hospital and long-term survival . J Am Coll Cardiol. 31:1998;294-300.
6. Prospective, multicenter study of the safety and feasibility of primary stenting in acute myocardial infarction in-hospital and 30-day results of the PAMI stent pilot trial . J Am Coll Cardiol. 31:1998;23-30.
7. The Thrombolysis in Myocardial Infarction (TIMI) trial phase 1 findings . N Engl J Med. 312:1985;932-936.
8. Kramer C.M., Rogers W.J., Theobald T.M., Power T.P., Petruolo S., Reichek N. Remote noninfarcted region dysfunction soon after first anterior myocardial infarction. Circulation. 94:1996;660-666.
9. Kern M.J., Moore J.A., Aguirre F.V., Bach R.G., Caracciolo E.A., Wolford T., Khoury A.F., Mechem C., Donohue T.J. Determination of angiographic (TIMI grade) blood flow by intracoronary doppler flow velocity during acute myocardial infarction. Circulation. 94:1996;1545-1552.
10. Gibson C.M., Ryan K.A., Murphy S.A., Mesley R., Marble S.J., Giugliano R.P., Cannon C.P., Antman E.M., Braunwald E. Impaired coronary blood flow in nonculprit arteries in the setting of acute myocardial infarction for the TIMI study group . J Am Coll Cardiol. 34:1999;974-982.
11. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. Circulation. 329:1993;1615-1622.
12. Vogt A., Von Essen R., Tebbe U., Feuerer W., Appel K.F., Neuhaus K.L. Impact of early reperfusion status of the infarct-related artery on short-term mortality after thrombolytic for acute myocardial infarction retrospective analysis of four German multicenter studies . J Am Coll Cardiol. 21:1993;1391-1395.
13. Gensini G.G., Bruto da Costa B.C. The coronary collateral circulation in living man. Am J Cardiol. 24:1969;393-400.
14. Choudhri T.F., Hoh B.L., Zerwes H.G., Prestigiacomo C.J., Kim S.C., Connolly E.S., Kottirsch G., Pinsky D.J. Reduced microvascular thrombosis and improved outcome in acute murine stroke by inhibiting GP IIb/IIIa receptor-mediated platelet aggregation. J Clin Invest. 102:1998;1301-1310.
15. Hamm C.W., Heeschen C., Goldmann B., Vahanian A., Adgey J., Miguel C.M., Rutsch W., Berger J., Kootstra J., Simoons M.L. Benefit of abximab in patients with refractory unstable angina in relation to serum troponin T levels. C7E3 Fab Antiplatelet Therapy in Unstable Refractory Angina (CAPTURE) Study Investigators. N Engl J Med. 340:1999;1623-1629.
16. Berger P.B., Ellis S.G., Holmes D.R., Granger C.B., Criger D.A., Betriu A., Topol E.J., Califf R.M. Relationship between delay in performing direct coronary angioplasty and early clinical outcome in patients with acute myocardial infarction results from the global use of strategies to open occluded arteries in acute coronary syndromes (GUSTO-IIb) trial . Circulation. 100:1999;14-20.
17. Holmes D.R., White H.D., Pieper K.S., Ellis S.G., Califf R.M., Topol E.J. Effect of age on outcome with primary angioplasty versus thrombolysis. J Am Coll Cardiol. 33:1999;412-419.
18. Brener S.J., Barr L.A., Burchenal J.E.B., Katz S., George B.S., Jones A.A., Cohen E.D., Gainey P.C., White H.J., Cheek H.B., Moses J.W., Moliterno D.J., Effron M.B., Topol E.J. Randomized, placebo-controlled trial of platelet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocardial infarction on behalf of the ReoPro and Primary PTCA Organization and Randomized Trial (RAPPORT) Investigators . Circulation. 98:1998;734-741.
19. [no authors listed] Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade: the EPISTENT Investigators: evaluation of Platelet IIb/IIIa inhibitor for Stenting. Lancet 1998;352:87-92.